Lifeline Biotechnologies, Inc. LLBO

Company Overview

Lifeline Biotechnologies, Inc. (OTC Pink: LLBO) is a U.S.-based medical technology and biotechnology company focused on the development of diagnostic technologies intended to support early disease detection, particularly in breast cancer screening. Public disclosures and historical company materials describe the company as operating within the healthcare technology and medical diagnostics industries, with an emphasis on non-invasive or adjunctive screening approaches designed to improve detection outcomes and patient comfort relative to conventional imaging procedures.

The company has historically centered its commercialization efforts around proprietary breast health screening technologies, including systems associated with physiological measurement and imaging analysis. Available public information indicates that Lifeline Biotechnologies has operated as a development-stage enterprise for much of its history, pursuing clinical validation, intellectual property development, and regulatory advancement rather than large-scale commercial revenue generation. Data regarding current revenue scale, commercial penetration, and operational activity is limited in recent public filings, and some operational details are inconclusive based on available public sources.